Rapport Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Rapport Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapport Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapport Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $48M | 1.6M | 29.70 |
| 2025-06-30 | $13M | 1.1M | 11.37 |
| 2025-03-31 | $11M | 1.1M | 10.03 |
| 2024-12-31 | $9.9M | 556k | 17.74 |
| 2024-09-30 | $10M | 507k | 20.48 |
| 2024-06-30 | $1.6M | 70k | 23.26 |